Written answers
Wednesday, 18 May 2022
Department of Health
Medicinal Products
John Lahart (Dublin South West, Fianna Fail)
Link to this: Individually | In context | Oireachtas source
177. To ask the Minister for Health when voretigene neparvovec luxturna will be added to the reimbursement list in line with the Health Act 2013 and the national framework agreed with the pharmaceutical industry under which a company must submit an application to the HSE to have a new medicine approved; and if he will make a statement on the matter. [24969/22]
Stephen Donnelly (Wicklow, Fianna Fail)
Link to this: Individually | In context | Oireachtas source
The HSE has statutory responsibility for decisions on pricing and reimbursement of medicines under the community drug schemes, in accordance with the provisions of the Health (Pricing and Supply of Medical Goods) Act 2013; therefore, the matter has been referred to the HSE for reply to the Deputy.
No comments